Highly rated Eli Lilly stock is this week's Big Cap 20 pick to watch as it attempts to take out a flat-base buy point.

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you size that up quickly. The stock recently ...

The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...

Fintel reports that on January 8, 2026, Morgan Stanley downgraded their outlook for Arcus Biosciences (NYSE:RCUS) from ...

Shares of Pacira BioSciences slipped after the company's preliminary-revenue report came in below Wall Street estimates. The stock fell 9.7%, to $23.49, in after-hours trading Thursday. Through the ...

Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. Olin cut its fourth-quarter outlook, citing a slowdown in ...

With U.S. stock markets set to open in two hours, Regencell Bioscience Holdings Ltd. (RGC) was up 13.5% in pre-market trading, and Kratos Defense & Security Solutions Inc. (KTOS) was up 12.4%.

Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation Acquisition builds on Lilly's established capabilities in inflammatory-me ...

Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ('Bright Minds” or the 'Company”) announces the pricing of its ...

After market close on Wednesday, U.S. pharmaceutical giant Eli Lilly (LLY) confirmed its plan to acquire Ventyx Biosciences (VTYX) for approximately $1.2 billion, further expanding its pipeline ...

As of Wednesday, January 07, Regencell Bioscience Holdings Limited’s RGC share price has surged by 20.07%, which has investors questioning if this is right time to sell.

Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...